Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 26

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats

Min, Weijie, Wu, Yina, Fang, Yibin, Hong, Bo, Dai, Dongwei, Zhou, Yu, Liu, Jianmin, Li, Qiang·2022·Bioengineered

Abstract

Mesenchymal stem cells (MSCs)-derived exosomes (Exo) are beneficial in the use of brain damages. Restrictively, the mechanism of Exo expressing miR-124-3p in hypoxic-ischemic brain damage (HIBD) is not completely comprehended. Thereupon, this work was put forward to reveal the action of bone marrow MSCs-derived Exo (BMSCs-Exo) expressing miR-124-3p in the illness. BMSCs were isolated and transfected with miR-124-3p agomir. Then, BMSCs-Exo were extracted and identified. The newborn HIBD rats were injected with miR-124-3p-modified BMSCs-Exo or tumor necrosis factor receptor associated factor 6 (TRAF6)-related vectors. Next, neurological functions, neuron pathological and structural damages, oxidative stress and neuronal apoptosis were observed. miR-124-3p and TRAF6 expression was tested, along with their targeting relationship. miR-124-3p was down-regulated, and TRAF6 was up-regulated in newborn HIBD rats. miR-124-3p targeted TRAF6. BMSCs-Exo improved neurological functions, alleviated neuron pathological and structural damages, suppressed oxidative stress and reduced neuronal apoptosis in newborn HIBD rats, whereas BMSCs-Exo-mediated effects were enhanced by restoring miR-124-3p. Silencing TRAF6 attenuated HIBD in newborn rats, but overexpression of TRAF6 reversed the protective role of miR-124-3p-overexpressing BMSCs-Exo. This work makes it comprehensive that up-regulated exosomal miR-124-3p ameliorates HIBD in newborn rats by targeting TRAF6, which replenishes the potential agents for curing HIBD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21655979.2021.2016094

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY-NC · PubMed Central
Figure 1. Identification of BMSCs and BMSCs-Exo. A. Morphology of BMSCs of P3; B. Analysis of surface markers by flow cytometry; C. TEM observed size and morphology of BMSCs-Exo; D. NTA of BMSCs-Exo; E. Western blot analysis of CD81 and CD9.
Figure 1. Identification of BMSCs and BMSCs-Exo. A. Morphology of BMSCs of P3; B. Analysis of surface markers by flow cytometry; C. TEM observed size and morphology of BMSCs-Exo; D. NTA of BMSCs-Exo; E. Western blot analysis of CD81 and CD9.CC BY-NC · PubMed Central
Figure 2. Successful HIBD modeling in rats. A. RT-qPCR detection of miR-124-3p and TRAF6 mRNA expression; B. Western blot detection of TRAF6 protein expression; C. Neurological function score of rats after HIBD; D. Behavioral function of rats after HIBD; E. HE staining; F. SOD and MDA levels of rats after HIBD; G. NO levels of rats after HIBD; H. TUNEL staining; I. Nissl staining; J. Bax and Bcl-2 protein expression of rats after HIBD; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the Sham group.
Figure 2. Successful HIBD modeling in rats. A. RT-qPCR detection of miR-124-3p and TRAF6 mRNA expression; B. Western blot detection of TRAF6 protein expression; C. Neurological function score of rats after HIBD; D. Behavioral function of rats after HIBD; E. HE staining; F. SOD and MDA levels of rats after HIBD; G. NO levels of rats after HIBD; H. TUNEL staining; I. Nissl staining; J. Bax and Bcl-2 protein expression of rats after HIBD; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the Sham group.CC BY-NC · PubMed Central
Figure 3. BMSCs-Exo improve HIBD in newborn rats. A. DiI-labeled Exo in the hippocampus of HIBD rats; B. Neurological function score of HIBD rats after injection with BMSCs-Exo; C. Behavioral function of HIBD rats after injection with BMSCs-Exo; D. HE staining; E. SOD and MDA levels of HIBD rats after injection with BMSCs-Exo; F. NO levels of HIBD rats after injection with BMSCs-Exo; G. TUNEL staining; H. Nissl staining; I. Bax and Bcl-2 protein expression in HIBD rats after injection with BMSCs-Exo; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the HIBD group.
Figure 3. BMSCs-Exo improve HIBD in newborn rats. A. DiI-labeled Exo in the hippocampus of HIBD rats; B. Neurological function score of HIBD rats after injection with BMSCs-Exo; C. Behavioral function of HIBD rats after injection with BMSCs-Exo; D. HE staining; E. SOD and MDA levels of HIBD rats after injection with BMSCs-Exo; F. NO levels of HIBD rats after injection with BMSCs-Exo; G. TUNEL staining; H. Nissl staining; I. Bax and Bcl-2 protein expression in HIBD rats after injection with BMSCs-Exo; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the HIBD group.CC BY-NC · PubMed Central
Figure 4. Up-regulated miR-124-3p further enhances the protective role of BMSCs-Exo on HIBD rats. A. miR-124-3p expression in HIBD rats after injection with Exo-miR-124-3p agomir; B. Neurological function score of HIBD rats after injection with Exo-miR-124-3p agomir; C. Behavioral function of HIBD rats after injection with Exo-miR-124-3p agomir; D. HE staining; E. SOD and MDA levels of HIBD rats after injection with Exo-miR-124-3p agomir; F. NO levels of HIBD rats after injection with Exo-miR-124-3p agomir; G. TUNEL staining; H. Nissl staining; I. Bax and Bcl-2 protein expression in HIBD rats after injection with Exo-miR-124-3p agomir; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the Exo-agomir NC group.
Figure 4. Up-regulated miR-124-3p further enhances the protective role of BMSCs-Exo on HIBD rats. A. miR-124-3p expression in HIBD rats after injection with Exo-miR-124-3p agomir; B. Neurological function score of HIBD rats after injection with Exo-miR-124-3p agomir; C. Behavioral function of HIBD rats after injection with Exo-miR-124-3p agomir; D. HE staining; E. SOD and MDA levels of HIBD rats after injection with Exo-miR-124-3p agomir; F. NO levels of HIBD rats after injection with Exo-miR-124-3p agomir; G. TUNEL staining; H. Nissl staining; I. Bax and Bcl-2 protein expression in HIBD rats after injection with Exo-miR-124-3p agomir; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the Exo-agomir NC group.CC BY-NC · PubMed Central
Figure 5. miR-124-3p targets TRAF6. A. Jefferson website predicted the binding site between TRAF6 and miR-124-3p; B. Dual luciferase reporter gene assay verified the targeting relationship between TRAF6 and miR-124-3p; C-D. RT-qPCR and Western blot analysis of TRAF6 expression in Exo; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the agomir NC group.
Figure 5. miR-124-3p targets TRAF6. A. Jefferson website predicted the binding site between TRAF6 and miR-124-3p; B. Dual luciferase reporter gene assay verified the targeting relationship between TRAF6 and miR-124-3p; C-D. RT-qPCR and Western blot analysis of TRAF6 expression in Exo; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the agomir NC group.CC BY-NC · PubMed Central
Figure 6. Depressing TRAF6 exerts protectively for rats with HIBD. A-B. RT-qPCR and Western blot analysis of TRAF6 expression in HIBD rats after injection with si-TRAF6; C. Neurological function score of HIBD rats after injection with si-TRAF6; D. Behavioral function of HIBD rats after injection with si-TRAF6; E. HE staining; F. SOD and MDA levels of HIBD rats after injection with si-TRAF6; G. NO levels of HIBD rats after injection with si-TRAF6; H. TUNEL staining; I. Nissl staining; J. Bax and Bcl-2 protein expression in HIBD rats after injection with si-TRAF6; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the si-NC group.
Figure 6. Depressing TRAF6 exerts protectively for rats with HIBD. A-B. RT-qPCR and Western blot analysis of TRAF6 expression in HIBD rats after injection with si-TRAF6; C. Neurological function score of HIBD rats after injection with si-TRAF6; D. Behavioral function of HIBD rats after injection with si-TRAF6; E. HE staining; F. SOD and MDA levels of HIBD rats after injection with si-TRAF6; G. NO levels of HIBD rats after injection with si-TRAF6; H. TUNEL staining; I. Nissl staining; J. Bax and Bcl-2 protein expression in HIBD rats after injection with si-TRAF6; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the si-NC group.CC BY-NC · PubMed Central
Figure 7. Elevating TRAF6 antagonizes miR-124-3p-mediated protection against HIBD in rats. A-B. RT-qPCR and Western blot analysis of TRAF6 expression in HIBD rats in rescue experiment; C. Neurological function score of HIBD rats in rescue experiment; D. Behavioral function of HIBD rats in rescue experiment; E. HE staining; F. SOD and MDA levels of HIBD rats in rescue experiment; G. NO levels of HIBD rats in rescue experiment; H. TUNEL staining; I. Nissl staining; J. Bax and Bcl-2 protein expression in HIBD rats in rescue experiment; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the Exo-miR-124-3p agomir + oe-NC group.
Figure 7. Elevating TRAF6 antagonizes miR-124-3p-mediated protection against HIBD in rats. A-B. RT-qPCR and Western blot analysis of TRAF6 expression in HIBD rats in rescue experiment; C. Neurological function score of HIBD rats in rescue experiment; D. Behavioral function of HIBD rats in rescue experiment; E. HE staining; F. SOD and MDA levels of HIBD rats in rescue experiment; G. NO levels of HIBD rats in rescue experiment; H. TUNEL staining; I. Nissl staining; J. Bax and Bcl-2 protein expression in HIBD rats in rescue experiment; measurement data were expressed as mean ± standard deviation; * P < 0.05 vs. the Exo-miR-124-3p agomir + oe-NC group.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 3

  1. Yang L, 2020, Histol Histopathol, 35, 929
  2. Xiao B, 2019, Biol Open, 8, 1
  3. Zhu L, 2020, Mol Med Rep, 22, 3944

Cited by

See all 26

Metadata

Authors
Min, W., Wu, Y., Fang, Y., Hong, B., Dai, D., Zhou, Y., Liu, J., & Li, Q.
Affiliations
Changhai Stroke Center, Changhai Hospital, Second Military Medical University, Shanghai China
Venue
Bioengineered
Published
2022-01-22
Volume
13
Issue
2
Pages
3195-3207
ISSN
  • 2165-5979
  • 2165-5987
Cited by
26
References
48
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. https://app.cochat.ai/papers/10.1080/21655979.2021.2016094
The paper
Min, W., Wu, Y., Fang, Y., Hong, B., Dai, D., Zhou, Y., Liu, J., & Li, Q. (2022). Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. Bioengineered. https://doi.org/10.1080/21655979.2021.2016094

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.